These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5816120)

  • 1. Definitive efficacy and safety testing for equine encephalomyelitis vaccine.
    Hays MB
    J Am Vet Med Assoc; 1969 Jul; 155(2):374-6. PubMed ID: 5816120
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to bivalent tissue culture origin equine encephalomyelitis vaccine.
    Gutekunst DE
    J Am Vet Med Assoc; 1969 Jul; 155(2):368-74. PubMed ID: 5816119
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic requirements and control for equine encephalomyelitis vaccines.
    Tamoglia TW
    J Am Vet Med Assoc; 1969 Jul; 155(2):376-9. PubMed ID: 5816121
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity against eastern and western equine encephalomyelitis viruses.
    Byrne RJ
    J Am Vet Med Assoc; 1969 Jul; 155(2):365-8. PubMed ID: 5816118
    [No Abstract]   [Full Text] [Related]  

  • 5. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
    Jochim MM; Barber TL; Luedke AJ
    J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae.
    Spertzel RO; Kahn DE
    J Am Vet Med Assoc; 1971 Sep; 159(6):731-8. PubMed ID: 5158756
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. I. Some data on the preparation and antigenicity tests of vaccines.
    Mansharamani HJ; Dandawate CN; Krishnamurthy BG
    Indian J Pathol Bacteriol; 1967 Jan; 10(1):9-24. PubMed ID: 6068256
    [No Abstract]   [Full Text] [Related]  

  • 9. Report of the panel for the symposium on immunity to selected equine infectious diseases.
    J Am Vet Med Assoc; 1969 Jan; 154(2):171-6. PubMed ID: 4303120
    [No Abstract]   [Full Text] [Related]  

  • 10. A dot-immunobinding assay for the detection of antibody to Getah virus in horses.
    Sugiura Y; Ohta C; Goto H
    Aust Vet J; 1989 Oct; 66(10):340-1. PubMed ID: 2818365
    [No Abstract]   [Full Text] [Related]  

  • 11. Serologic investigations on arbovirus infections in Romania.
    Drăgănescu N; Gheorghiu V; Dincă A
    Rev Roum Inframicrobiol; 1971; 8(2):57-61. PubMed ID: 5170831
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN; Wisseman CL; Rosenzweig EC; Harrington BR; Kitaoka M
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract]   [Full Text] [Related]  

  • 13. Tahyna virus in foals.
    Bárdos V; Cupková J; Jakubík J
    Acta Virol; 1965 Nov; 9(6):555. PubMed ID: 4379442
    [No Abstract]   [Full Text] [Related]  

  • 14. [An equine influenza vaccine].
    Böhm HO; Panjević D
    Berl Munch Tierarztl Wochenschr; 1968 Oct; 81(19):392-5. PubMed ID: 5693740
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses.
    Waldridge BM; Wenzel JG; Ellis AC; Rowe-Morton SE; Bridges ER; D'Andrea G; Wint R
    Vet Ther; 2003; 4(3):242-8. PubMed ID: 15136985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
    Bogdan JR; Morley PS; Townsend HG; Haines DM
    Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a modified virus strain and vaccine for equine viral arteritis.
    McCollum WH
    J Am Vet Med Assoc; 1969 Jul; 155(2):318-22. PubMed ID: 4978804
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. II. Safety testing of the vaccine in cortisone sensitized Swiss albino mice.
    Mansharamani HJ; Dandawate CN
    Indian J Pathol Bacteriol; 1967 Jan; 10(1):25-32. PubMed ID: 6036490
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
    Monlux WS; Luedke AJ; Mercado S; Rosales JC
    J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 5074265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.